Sio Capital Management, LLC Chemo Centryx, Inc. Transaction History

Sio Capital Management, LLC

$189 Million
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 May 15, 2019	BUY	$10.01 - $13.89 $3.61 Million - $5.01 Million	360,918 Added 213.24%	530,175 $7.36 Million
Q4 2018 Feb 14, 2019	BUY	$9.15 - $12.26 $1.55 Million - $2.08 Million	169,257 New	169,257 $1.85 Million
Q1 2018 May 15, 2018	SELL	$5.9 - $14.99 $492,225 - $1.25 Million	-83,428 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$5.53 - $8.42 $322,100 - $490,431	58,246 Added 231.3%	83,428 $496,000
Q3 2017 Nov 14, 2017	BUY	$6.5 - $10.69 $163,683 - $269,195	25,182	25,182 $187,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.